Increase in motor neuron disease mortality in Spain: Temporal and geographical analysis (1990-2005)

Amyotrophic Lateral Sclerosis

Volumn 12, Issue 3, 2011, Pages 192-198

  Alonso, Veronica ^a,b   Villaverde Hueso, Ana ^a,b   Hens, Manuel J ^a   Morales Piga, Antonio ^a   Abaitua, Ignacio ^a,b   De La Paz, Manuel Posada ^a,b  

^a Instituto de Salud Carlos III   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

amyotrophic lateral sclerosis; Mortality; motor neuron diseases; Spain

Indexed keywords

ADULT; AGED; ARTICLE; CAUSE OF DEATH; DISEASE CLASSIFICATION; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOTOR NEURON DISEASE; PRIORITY JOURNAL; SEX DIFFERENCE; SPAIN;

AGED; ENVIRONMENTAL EXPOSURE; FEMALE; GEOGRAPHY; HEALTH SERVICES; HUMANS; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; REGISTRIES; SPAIN;

EID: 79955774497     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482968.2010.543688     Document Type: Article

References (36)

1. Mitchell JD, Borasio GD. Amyotrophic lateral sclerosis. Lancet. 2007;369:2031-41.
2. Uccelli R, Binazzi A, Altavista P, Belli S, Comba P, Mastrantonio M, et al. Geographic distribution of amyotrophic lateral sclerosis through motor neuron disease mortality data. Eur J Epidemiol. 2007;22:781-90. (Pubitemid 350105363)
3. Worms PM. The epidemiology of motor neuron diseases: a review of recent studies. J Neurol Sci. 2001;191:3-9. (Pubitemid 33035889)
4. Fang F, Valdimarsdóttir U, Bellocco R, Ronnevi LO, Sparén P, Fall K, et al. Amyotrophic lateral sclerosis in Sweden, 1991-2005. Arch Neurol. 2009;66:515-9.
5. Gunnarsson LG, Lindberg G, Söderfelt B, Axelson O. The mortality of motor neuron disease in Sweden. Arch Neurol. 1990;47:42-6. (Pubitemid 20024152)
6. Veiga-Cabo J, Almazá n-Isla J, Sendra-Gutié rrez JM, de Pedro-Cuesta J. Differential features of motor neuron disease mortality in Spain. Int J Epidemiol. 1997;26:1024-32. (Pubitemid 27478519)
7. Maasilta P, Jokelainen M, Löytönen M, Sabel CE, Gatrell AC. Mortality from amyotrophic lateral sclerosis in Finland, 1986-1995. Acta Neurol Scand. 2001;104:232-5. (Pubitemid 32844270)
8. Noonan CW, White MC, Thurman D, Wong LY. Temporal and geographic variation in United States motor neuron disease mortality, 1969-1998. Neurology. 2005;64: 1215-21.
9. Day TG, Scott M, Perring R, Doyle P. Motor neuron disease mortality in Great Britain continues to rise: examination of mortality rates 1975-2004. Amyotroph Lateral Scler. 2007; 8:337-42. (Pubitemid 350176931)
10. Neilson S, Robinson I, Alperovitch A. Rising amyotrophic lateral sclerosis mortality in France, 1968-1990: increased life expectancy and inter-disease competition as an explanation. J Neurol. 1994;241:448-55. (Pubitemid 24194070)
11. Gil J, Funalot B, Torny F, Lacoste M, Couratier P. Exogenous risk factors in sporadic ALS: a review of the literature. Rev Neurol (Paris). 2007;163:1021-30. (Pubitemid 350261575)
12. Beleza-Meireles A, Al-Chalabi A. Genetic studies of amyotrophic lateral sclerosis: controversies and perspectives. Amyotroph Lateral Scler. 2009;10:1-14.
13. Matías-Guíu J, Galán L, García-Ramos R, Vela A, Guerreo A. Epidemiolog í a descriptiva de la esclerosis lateral amiotr ó-fica. Neurolog í a. 2007;22:368-80. (Pubitemid 47123008)
14. Velleman PF. Definition and comparison of robust nonlinear data smoothing algorithms. J Am Statist Assoc. 1980;75:609-15.
15. Besag J, York JC, Mollié A. Bayesian image restoration, with two applications in spatial statistics (with discussion). Ann Inst Statist Math. 1991;43:1-59.
16. Neilson S, Robinson I, de Pedro-Cuesta J, Veiga-Cabo J. Decline and rise of mortality from motor neuron disease in Spain, 1960-1989: demographic, environmental and competitive infl uences. Neuroepidemiology. 1996;15: 180-91.
17. Llorca Dí az J, Prieto Salceda MD, Delgado-Rodr í guez M. An á lisis del efecto de cohorte en la evoluci ó n de la mortalidad por enfermedad de la motoneurona en Espa ñ a, 1951-1992. Rev Esp Salud P ú blica. 1999;73:481-8.
18. Seljeseth YM, Vollset SE, Tysnes OB. Increasing mortality from amyotrophic lateral sclerosis in Norway? Neurology. 2000;55:1262-6.
19. Berlowitz DJ, Detering K, Schachter L. A retrospective analysis of sleep quality and survival with domiciliary ventilatory support in motor neuron disease. Amyotroph Lateral Scler. 2006;7:100-6. (Pubitemid 43878831)
20. Murphy M, Quinn S, Young J, Parkin P, Taylor B. Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study. Neurology. 2008;71:1889-95.
21. The Scottish Motor Neuron Disease Research Group. The Scottish Motor Neuron Disease Register: a prospective study of adult onset motor neuron disease in Scotland. Methodology, demography and clinical features of incident cases in 1989. J Neurol Neurosurg Psychiatry. 1992; 55:536-41.
22. Durlleman S, Alperovitch A. Increasing trend of ALS in France and elsewhere: are the changes real? Neurology. 1989;39;768-73. (Pubitemid 19150148)
23. Sejvar JJ, Holman RC, Breesee JS, Kochanek KD, Schoenberger LB. Amyotrophic lateral sclerosis mortality in the United States, 1979-2001. Neuroepidemiology. 2005; 25:144-52. (Pubitemid 41207067)
24. Forbes RB, Colville S, Swingler RJ, Scottish ALS/MND Register. The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 years or above. Age Ageing. 2004;33:131-4. (Pubitemid 38313110)
25. Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study. Neurology. 2009;72:1640-5.
26. National Statistics Institute of Spain (Instituto Nacional de Estad í stica). Localizaci ó n y Especializaci ó n de la Industria [Internet]. In: Panor á mica de la Industria. 2010 [cited 2010 Jun]. Available from: http://www.ine.es/prodyser/pubweb/pan- ind/INDweb.pdf.
27. Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology. 2007; 68:1002-7. (Pubitemid 46569133)
28. Landers JE, Melki J, Meininger V, Glass JD, van den Berg LH, van Es MA, et al. Reduced expression of the kinesinassociated protein 3 (KIFAP3) gene increases survival in amyotrophic lateral sclerosis. PNAS. 2009;106:9004-9.
29. Morahan JM, Yu B, Trent RJ, Pamphlett R. Genetic susceptibility to environmental toxicants in ALS. Am J Med Genet. 2007;144:885-90. (Pubitemid 47547988)
30. Armon C. An evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis. Neuroepidemiology. 2003;22:217-28. (Pubitemid 36693864)
31. Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. Orphanet J Rare Dis. 2009;4:3.
32. Chio A, Magnani C, Oddenino E, Tolardo G, Schiffer D. Accuracy of death certificate diagnosis of amyotrophic lateral sclerosis. J Epidemiol Community Health. 1992;46:517-8.
33. Douglass CP, Kandler RH, Shaw PJ, McDermott CJ. An evaluation of neurophysiological criteria used in the diagnosis of motor neuron disease. J Neurol Neurosurg Psychiatry. 2010;81:646-9.
34. Nygren I, Antonova K, Mattsson P, Askmark H. The ALS/MND prevalence in Sweden estimated by riluzole sales statistics. Acta Neurol Scand. 2005;111:180-4. (Pubitemid 40278584)
35. Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293-9.
36. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial ' Clinical limits of amyotrophic lateral sclerosis ' workshop contributors. J Neurol Sci. 1994;124(Suppl):96-107.